Plasma prolactin in patients with colorectal cancer

BMC Cancer

Volumn 4, Issue , 2004, Pages

  Soroush, Ahmad Reza ^a   Mahmood Zadeh, Hosein ^a   Moemeni, Mehrnush ^a   Shakiba, Behnam ^b   Elmi, Sara ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; PROLACTIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC KIT; FEMALE; HUMAN; HYPERPROLACTINEMIA; IMMUNORADIOMETRIC ASSAY; MALE; PROLACTIN BLOOD LEVEL; BLOOD; COLORECTAL TUMOR; CROSS-SECTIONAL STUDY; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROLACTIN; TUMOR MARKERS, BIOLOGICAL;

EID: 13144285682     PISSN: 14712407     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2407-4-97     Document Type: Article

References (22)

1. Feezor RJ, Copeland , Edward M, Hochwald , Steven N: Significance of Micrometastases in Colorectal Cancer. Annals of Surgical Oncology 2002, 9(10):944-953.
2. Towler BP, Irwig L, Glasziou P, Weller D, Kewenter J: Screening for colorectal cancer using the faecal occult blood test, Hemoccult. [Systematic Review] Cochrane Colorectal Cancer Group. Cochrane Database Syst Rev 2000, 2:. CD00 1216. Review
3. Adams , Warwick J, Morris , David L: Carcinoembryonic antigen in the evaluation of therapy of primary and metastatic colorectal cancer. Australian & New Zealand Journal of Surgery 1996, 66(8):515-519.
4. Konishi F: CEA doubling time and CEA half-life in the prediction of recurrences after Colorectal Cancer Surgery. Japanese Journal of Clinical Oncology 2002, 32:41-42.
5. Jonathan NB, Liby K, McFarland M, Zinger M: Prolactin as an autocrine/paracrine growth factor in human cancer. TRENDS in Endocrinology & Metabolism 2002, 13:6.
6. Dugan A, Schwemberger S, Babcock GF, Buckley D, Buckley AR, Ogle CK, Horseman ND: Effects of Prolactin Level on Burn-Induced Aberrations in Myelopoiesis. Shock 2004, 21(2):151-159.
7. Llovera M, Touraine P, Kelly PA, Goffin V: Involvement of prolactin in breast cancer: redefining the molecular targets. Experimental Gerontology 2000, 35:41-51.
8. Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW: Extrapituitary prolactin: distribution, regulation, functions and clinical aspects. Endocr Rev 1996, 17:639-669.
9. Rees LH, Bloomfield GA, Rees GM, Corrin B, Franks LM, Ratcliffe JG: Multiple hormones in a bronchial tumor. J Clin Endocrinol Metab 1974, 38:1090-7.
10. Stanisic TH, Donovan J: Prolactin secreting renal cell carcinoma. J Urol 1986, 136:85-6.
11. Hsu CT, Yu MH, Gregory Lee CY, Jong HL, Yeh MY: Ectopic production of Prolactin in uterine cervical carcinoma. Gynecologic Oncol 1992, 44:166-71.
12. Hoffman WH, Gala RR, Kovacs K, Subramanian MG: Ectopic prolactin secretion from a gonadoblastoma. Cancer 1987, 60: 690-5.
13. Mujagic Z, Mujagic H: Importance of serum prolactin determination in metastatic breast cancer patients. Croat Med J 2004, 45(2):176-80.
14. Bhatavdekar JM, Patel DD, Chikhlikar PR, Shah NG, Vora HH, Ghosh N, Trivedi TI: Ectopic production of prolactin by colorectal adenocarcinoma. Dis Colon Rectum 2001, 44(1):119-27.
15. Indinnimeo M, Cicchini C, Memeo L, Stazi A, Ghini C, Ricci F, Reale MG, Mingazzini P: Plasma and tissue prolactin detection in colon carcinoma. Oncol Rep 2001, 8(6):1351-3.
16. Carlson HE, Zarrabi MH, Lyubsky SL: Lack of association between hyperprolactinemia and colon carcinoma. Cancer Invest 2000, 18(2):130-4.
17. Bhatavdekar JM, Patel DD, Chikhlikar PR, Shah NG, Vora HH, Ghosh N, Trivedi TI: Ectopic Production of Prolactin by Colorectal Adenocarcinoma. Dis Colon Rectum 2001, 44(1):119-127.
18. Patel DD, Bhatavdekar JM, Ghosh N, Vora HH, Karelia NH, Shah NG, Suthar TP, Balar DB, Trivedi CR: Plasma prolactin in patients with colorectal cancer. Value in follow-up and as a prognosticator. Cancer 1994, 73(3):570-4.
19. Ilan Y, Sibirsky O, Livni N, Gofrit O, Barack V, Goldin E: Dig Dis Sci 1995, 40:2010-5.
20. Baert D, Matthys C, Gillardin JP, Lepoutre L, Thienpont L, Kaufman JM, Cuvelier C, De Vos M: Prolactin and colorectal cancer: is there a connection? Acta Gastroenterol Belg 1998, 61(4 : 07-9.
21. Fletcher RH: CEA monitoring after surgery for colorectal cancer: When is the evidence sufficient? JAMA 1993, 270(8 : 87-8.
22. Bhatavdekar JM, Patel DD, Giri DD, Karelia NH, Vora HH, Ghosh N, Shah NG, Triyedi SN, Balar DB: Comparison of plasma prolactin and CEA in monitoring patients with adenocarcinoma of colon and rectum. Br J Cancer 1992, 66(5):977-80.